BriaCell Therapeutics Cor... (BCTXW)
0.08
-0.01 (-11.11%)
At close: Apr 21, 2025, 3:18 PM
0.09
12.37%
After-hours: Apr 21, 2025, 04:00 PM EDT
-11.11% (1D)
| Bid | 0.07 |
| Market Cap | 296.67K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.1 |
| Volume | 18,367 |
| Avg. Volume (20D) | 103,101.078 |
| Open | 0.07 |
| Previous Close | 0.09 |
| Day's Range | 0.06 - 0.09 |
| 52-Week Range | 0.06 - 0.09 |
| Beta | 1.71 |
About BCTXW
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corpor...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 16
Stock Exchange NASDAQ
Ticker Symbol BCTXW
Website https://briacell.com